Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.

Journal of Controlled Release : Official Journal of the Controlled Release Society
Amit K SharmaA V Kabanov

Abstract

Doxorubicin (Dox) incorporated in nanosized polymeric micelles, SP1049C, has shown promise as monotherapy in patients with advanced esophageal carcinoma. The formulation contains amphiphilic block copolymers, Pluronics, that exhibit the unique ability to chemosensitize multidrug resistant (MDR) tumors by inhibiting P-glycoprotein (Pgp) drug efflux system and enhancing pro-apoptotic signaling in cancer cells. This work evaluates whether a representative block copolymer, Pluronic P85 (P85) can also prevent development of Dox-induced MDR in leukemia cells. For in vitro studies murine lymphocytic leukemia cells (P388) were exposed to increasing concentrations of Dox with/without P85. For in vivo studies, BDF1 mice bearing P388 ascite were treated with Dox or Dox/P85. The selected P388 cell sublines and ascitic tumor-derived cells were characterized for Pgp expression and functional activity (RT-PCR, Western Blot, rhodamine 123 accumulation) as well as Dox resistance (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay). The global gene expression was determined by oligonucleotide gene microarrays. We demonstrated that P85 prevented development of MDR1 phenotype in leukemia cells in vitro and in vivo as determined by ...Continue Reading

Citations

Mar 30, 2011·International Journal of Nanomedicine·Jun WangXuemei Wang
Apr 1, 2009·Nanomedicine·Denis B Buxton
May 24, 2014·British Journal of Cancer·X YangZ Duan
Nov 22, 2014·Nanomedicine·Giuseppe VisaniAlessandro Isidori
Sep 18, 2014·Expert Opinion on Drug Delivery·Susana Mn SimõesCarmen Alvarez-Lorenzo
Dec 14, 2011·Advanced Drug Delivery Reviews·Yan Chen, Lihong Liu
Sep 30, 2014·Molecular Pharmaceutics·Jianqin LuSong Li
Jun 20, 2015·Chemical Reviews·Yuanzeng MinAndrew Z Wang
Jun 27, 2015·Colloids and Surfaces. B, Biointerfaces·Isabel Sandez-MachoCarmen Alvarez-Lorenzo
Jun 21, 2014·Molecular Pharmaceutics·Daria Y Alakhova, Alexander V Kabanov
Sep 1, 2015·International Journal of Pharmaceutics·Anita BahadurPratap Bahadur
Apr 24, 2015·International Journal of Cancer. Journal International Du Cancer·Xiaoqian YangZhenfeng Duan
Apr 14, 2015·International Journal of Pharmaceutics·Jin RenJing Yao
Oct 15, 2013·Advanced Drug Delivery Reviews·Yi ZhaoAlexander V Kabanov
Jul 31, 2013·Colloids and Surfaces. B, Biointerfaces·Tao JiangRen-Xi Zhuo
Oct 4, 2012·Bioorganic & Medicinal Chemistry Letters·María L CuestasVerónica L Mathet
Jul 30, 2014·Frontiers in Pharmacology·Sonali Kapse-MistryMayur Yergeri
May 6, 2014·Frontiers in Pharmacology·Aditi M Jhaveri, Vladimir P Torchilin
Jan 16, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elena V BatrakovaAlexander V Kabanov
Sep 14, 2016·Langmuir : the ACS Journal of Surfaces and Colloids·Nazar Ileri ErcanRoland Faller
Jan 20, 2017·CNS Drugs·Mayur M Patel, Bhoomika M Patel
Feb 27, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Fatemeh Sadat Tabatabaei MirakabadSang Woo Joo
Aug 29, 2019·The Journal of Pharmacy and Pharmacology·Emiliano Alberto GentileVerónica Lidia Mathet
Nov 23, 2019·Nanomedicine : Nanotechnology, Biology, and Medicine·Yi ZhaoAlexander V Kabanov
May 24, 2019·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hangting HuTatiana K Bronich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Tamara MinkoA V Kabanov
Journal of Controlled Release : Official Journal of the Controlled Release Society
E V Batrakova, A V Kabanov
Journal of Controlled Release : Official Journal of the Controlled Release Society
A V KabanovValery Alakhov
© 2022 Meta ULC. All rights reserved